EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)

Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, dexamethasone or lenalidomide alone

Tadeusz Kubicki, Krzysztof Jamroziak, Paweł Robak, Jarosław Czyż, Agata Tyczyńska, Agnieszka Druzd-Sitek, Krzysztof Giannopoulos, Tomasz Wróbel, Adam Nowicki, Tomasz Szczepaniak, Anna Łojko-Dankowska, Magdalena Matuszak und 14 weitere

Polish Archives of Internal Medicine · 2024

DOI: 10.20452/pamw.16749 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Polish Archives of Internal Medicine, 2024. Verfasst von Tadeusz Kubicki und 25 weiteren Autor:innen. Beteiligte Einrichtung: Section of Hematology / Oncology, University of Chicago, University of Chicago, Chicago, Illinois, United States. Hauptthemen laut MEDLINE: Multiple Myeloma, Lenalidomide, Dexamethasone, Oligopeptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaLenalidomideDexamethasoneOligopeptidesQuality of LifeAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleMiddle AgedAgedThalidomide

Substanzen

LenalidomideDexamethasonecarfilzomibOligopeptidesThalidomide

Autor:innen und Institutionen

  • Section of Hematology / Oncology, University of Chicago, University of Chicago, Chicago, Illinois, United States
  • Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland
  • Department of Hematology, Institute of Hematology and Transfusion Medicine, Warszawa, Poland
  • Department of Hematology, Medical University of Lodz, Łódź, Poland
  • Department of Hematology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland
  • Department of Hematology and Transplantology, Medical University of Gdansk, Gdańsk, Poland

Zitieren

APA

Kubicki, T., Jamroziak, K., Robak, P., Czyż, J., Tyczyńska, A., Druzd-Sitek, A., Giannopoulos, K., Wróbel, T., Nowicki, A., Szczepaniak, T., Łojko-Dankowska, A., Matuszak, M., Gil, L., Puła, B., Szukalski, Ł., Końska, A., Zaucha, J. M., Walewski, J., Mikulski, D., …, & Dytfeld, D. (2024). Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, dexamethasone or lenalidomide alone. Polish Archives of Internal Medicine. https://doi.org/10.20452/pamw.16749

Vancouver

Kubicki T, Jamroziak K, Robak P, Czyż J, Tyczyńska A, Druzd-Sitek A, et al. Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, dexamethasone or lenalidomide alone. Polish Archives of Internal Medicine. 2024. doi:10.20452/pamw.16749

BibTeX
@article{Kubicki2024,
  author = {Kubicki, Tadeusz and Jamroziak, Krzysztof and Robak, Paweł and Czyż, Jarosław and Tyczyńska, Agata and Druzd-Sitek, Agnieszka and Giannopoulos, Krzysztof and Wróbel, Tomasz and Nowicki, Adam and Szczepaniak, Tomasz and Łojko-Dankowska, Anna and Matuszak, Magdalena and Gil, Lidia and Puła, Bartosz and Szukalski, Łukasz and Końska, Agnieszka and Zaucha, Jan M and Walewski, Jan and Mikulski, Damian and Czabak, Olga and Robak, Tadeusz and Kruk-Kwapisz, Dorota and Derman, Benjamin A and Major, Ajay and Jakubowiak, Andrzej J and Dytfeld, Dominik},
  title = {Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, dexamethasone or lenalidomide alone},
  journal = {Polish Archives of Internal Medicine},
  year = {2024},
  doi = {10.20452/pamw.16749}
}
Kostenlos starten →